Blockbuster - MM+M - Medical Marketing and Media

Blockbuster

All articles by Blockbuster

The next five years of pharma: Pricing, biosimilars, and specialty medicines
The next five years of pharma: Pricing, biosimilars, and specialty medicines
Alison Kanski
January 29, 2019
10:11 am

A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.

How pharma and healthcare shifted strategies post-blockbuster drug success
How pharma and healthcare shifted strategies post-blockbuster drug success
Mike Collins, Remedy Health Media
May 4, 2018
6:00 pm

Remedy Health Media’s Mike Collins discusses ways pharma and healthcare companies have shifted their strategies in the years after the success of blockbuster drugs.

Five things for pharma marketers to know: Thursday, July 28, 2016
Five things for pharma marketers to know: Thursday, July 28, 2016
Jaimy Lee
July 28, 2016
1:55 pm

Vertex says Orkambi is on the blockbuster track; Advent and CVC reportedly made offers to buy inVentiv Health; the FDA approves Sanofi’s Adlyxin

Five things for pharma marketers to know: Friday, March 25, 2016
Five things for pharma marketers to know: Friday, March 25, 2016
Jaimy Lee
March 25, 2016
2:20 pm

Gilead to pay Merck $200 million in HCV patent infringement suit; some patients aren’t prescribed blood thinners; the FDA issues generic opioid guidance

Five things for pharma marketers to know: Wednesday, February 3, 2016
Five things for pharma marketers to know: Wednesday, February 3, 2016
Jaimy Lee
February 3, 2016
1:35 pm

Seven potential blockbusters set to launch in 2016; Amarin case may lead to ‘misleading’ marketing; Valeant, Turing raised prices to meet preset targets

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners